Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Sarcoma|June 2, 2018
High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS PatientsAnne J Schuster, Leo Kager, Peter Reichardt, et al.
Histopathology|May 15, 2021
H3F3A-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three casesBenedikt Leinauer, Eduard Wolf, Mathias Werner, et al.
Pediatric Blood & Cancer|September 30, 2024
Osteosarcoma as a secondary malignancy following rhabdomyosarcoma: A report of 28 affected patients from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Stefanie Hecker-Nolting, et al.
Cancer Medicine|September 9, 2025
Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Vanessa Mettmann, Daniel Baumhoer, et al.
Anticancer Research|October 28, 2025
Osteosarcoma of the Diaphysis: A Report from the Cooperative Osteosarcoma Study Group (COSS)Stefan S Bielack, Claudia Blattmann, Leo Kager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2020
Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) PatientsLisa Marie Kelley, Miriam Schlegel, Stefanie Hecker-Nolting, et al.
Tumori|December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcomaStefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.
The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.
Pageof 4